Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study
Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 32, pp. 3231-3239
Open Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

Post-traumatic stress disorder: A differential diagnostic consideration for COVID-19 survivors
Erin T. Kaseda, Andrew J. Levine
The Clinical Neuropsychologist (2020) Vol. 34, Iss. 7-8, pp. 1498-1514
Closed Access | Times Cited: 168
Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group
Samantha Mayo, Maryam B. Lustberg, Haryana M. Dhillon, et al.
Supportive Care in Cancer (2020) Vol. 29, Iss. 6, pp. 2821-2840
Closed Access | Times Cited: 108
Progression of cognitive decline before and after incident stroke
Fanfan Zheng, Li Yan, Bao‐Liang Zhong, et al.
Neurology (2019) Vol. 93, Iss. 1
Closed Access | Times Cited: 94
Pretreatment Cancer-Related Cognitive Impairment—Mechanisms and Outlook
Brennan Olson, Daniel L. Marks
Cancers (2019) Vol. 11, Iss. 5, pp. 687-687
Open Access | Times Cited: 85
Opportunities for cannabis in supportive care in cancer
Amber S. Kleckner, Ian R. Kleckner, Charles Kamen, et al.
Therapeutic Advances in Medical Oncology (2019) Vol. 11
Open Access | Times Cited: 82
Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx
Lynne I. Wagner, Robert J. Gray, Joseph A. Sparano, et al.
Journal of Clinical Oncology (2020) Vol. 38, Iss. 17, pp. 1875-1886
Open Access | Times Cited: 82
Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach?
Sanne B. Schagen, Andrey S. Tsvetkov, Annette Compter, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 3, pp. 173-185
Closed Access | Times Cited: 65
Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysis
AnnaLynn M. Williams, Carly Paterson Khan, Charles E. Heckler, et al.
Breast Cancer Research and Treatment (2021) Vol. 187, Iss. 1, pp. 275-285
Open Access | Times Cited: 59
Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy
Noemí Cerulla, J. Blas Navarro, Núria de la Osa
Journal of Cancer Survivorship (2020) Vol. 14, Iss. 4, pp. 464-482
Closed Access | Times Cited: 54
Physical Activity Patterns and Relationships With Cognitive Function in Patients With Breast Cancer Before, During, and After Chemotherapy in a Prospective, Nationwide Study
Elizabeth A. Salerno, Eva Culakova, Amber S. Kleckner, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 29, pp. 3283-3292
Open Access | Times Cited: 54
Cancer-Related Cognitive Impairment in Patients With a History of Breast Cancer
Kathleen Van Dyk, Patricia A. Ganz
JAMA (2021) Vol. 326, Iss. 17, pp. 1736-1736
Open Access | Times Cited: 42
Cancer-related cognitive impairment: current perspectives on the management of cognitive changes following cancer treatment
Giulia Binarelli, Mylène Duivon, Florence Joly, et al.
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 3, pp. 249-268
Closed Access | Times Cited: 18
Randomized Controlled Trial of Virtually Delivered Cognitive Behavioral Therapy for Insomnia to Address Perceived Cancer-Related Cognitive Impairment in Cancer Survivors
Sheila N. Garland, Joshua Tulk, Josée Savard, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 17, pp. 2094-2104
Closed Access | Times Cited: 6
Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer
Lauren Otto, Corena V. Grant, Ashley A. Lahoud, et al.
Brain Behavior and Immunity (2024) Vol. 120, pp. 208-220
Closed Access | Times Cited: 6
Longitudinal Relationship Between Frailty and Cognition in Patients 50 Years and Older with Breast Cancer
Allison Magnuson, Lianlian Lei, Nikesha Gilmore, et al.
Journal of the American Geriatrics Society (2019) Vol. 67, Iss. 5, pp. 928-936
Open Access | Times Cited: 53
The Relationship Between Insomnia and Cognitive Impairment in Breast Cancer Survivors
Kevin T. Liou, Tim A. Ahles, Sheila N. Garland, et al.
JNCI Cancer Spectrum (2019) Vol. 3, Iss. 3
Open Access | Times Cited: 48
Cognitive Function in Older Adults With Cancer: Assessment, Management, and Research Opportunities
Allison Magnuson, Tim A. Ahles, Bihong T. Chen, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 19, pp. 2138-2149
Open Access | Times Cited: 40
A video-game based cognitive training for breast cancer survivors with cognitive impairment: A prospective randomized pilot trial
Anne Bellens, Ella Roelant, Bernard Sabbe, et al.
The Breast (2020) Vol. 53, pp. 23-32
Open Access | Times Cited: 39
Longitudinal Analysis of Depression and Anxiety Symptoms as Independent Predictors of Neurocognitive Function in Primary Brain Tumor Patients
M.D. Tibbs, Minh‐Phuong Huynh‐Le, Anny Reyes, et al.
International Journal of Radiation Oncology*Biology*Physics (2020) Vol. 108, Iss. 5, pp. 1229-1239
Open Access | Times Cited: 39
Cognitive Effects and Depression Associated With Taxane-Based Chemotherapy in Breast Cancer Survivors: A Meta-Analysis
Eiman Ibrahim, Ilaria Domenicano, Kate Nyhan, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 38
Change in Patients’ Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma
Anna Barata, Aasha I. Hoogland, Anuhya Kommalapati, et al.
Transplantation and Cellular Therapy (2022) Vol. 28, Iss. 7, pp. 401.e1-401.e7
Open Access | Times Cited: 26
Advances of neuroimaging in chemotherapy related cognitive impairment (CRCI) of patients with breast cancer
Senbang Yao, Qianqian Zhang, Xinxin Yao, et al.
Breast Cancer Research and Treatment (2023) Vol. 201, Iss. 1, pp. 15-26
Closed Access | Times Cited: 13
Associations of brain‐derived neurotrophic factor rs6265 polymorphism and cognitive function in breast cancer survivors from a cross‐sectional study
T. Goto, Leorey N. Saligan, Xiaobai Li, et al.
Cancer Medicine (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 5
Immune checkpoint inhibitors and cancer-related cognitive decline: a propensity score matched analysis in active chemotherapy patients
Guangmin Jian, Jiling Zeng, Jun Lü, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Digital multimodal intervention for cancer-related cognitive impairment in breast-cancer patients: Cog-Stim feasibility study
Giulia Binarelli, Florence Joly, François Christy, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top